Results for tag: "Low Grade Upper Tract Urothelial Cancer Drug"

The Low Grade Upper Tract Urothelial Cancer Drug market is a subset of the larger Bladder Cancer Drugs market. Low Grade Upper Tract Urothelial Cancer is a type of bladder cancer that affects the upper urinary tract, including the kidneys and ureters. Treatment for this type of cancer typically involves chemotherapy, radiation, and/or surgery. Drugs used to treat Low Grade Upper Tract Urothelial Cancer include immunotherapy, targeted therapy, and chemotherapy. Immunotherapy drugs work by stimulating the body's immune system to fight cancer cells, while targeted therapy drugs target specific molecules on cancer cells to stop them from growing and spreading. Chemotherapy drugs are used to kill cancer cells. Companies in the Low Grade Upper Tract Urothelial Cancer Drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, and Roche. Show Less Read more